Impact of Implementing the Paris System for Reporting Urine Cytology in the Performance of Urine Cytology A Correlative Study of 124 Cases
|
|
- Augustus Bell
- 5 years ago
- Views:
Transcription
1 Impact of Implementing the Paris System for Reporting Urine Cytology in the Performance of Urine Cytology A Correlative Study of 124 Cases Muhannad Hassan, MD, 1 Sharaddha Solanki, MSc, 2 Wassim Kassouf, MD, 2 Yonca Kanber, MD, 1 Derin Caglar, MD, 1 Manon Auger, 1 and Fadi Brimo, MD 1 From the Departments of 1 Pathology and 2 Urology, McGill University and McGill University Health Center, Montreal, Canada. Key Words: Paris System for Reporting Urine Cytology; Urine; Cytology; Performance; Atypical; High grade; Correlation Am J Clin Pathol September 2016;146: DOI: /AJCP/AQW127 ABSTRACT Objectives: We assessed the performance of urine cytology using the Paris System for Reporting Urine Cytology (PSRUC) in comparison to our current system. Methods: In total, 124 specimens with histologic correlation were reviewed and assigned to the PSRUC categories: benign, atypical urothelial cells (AUCs), suspicious for high-grade urothelial carcinoma (SHGUC), and high-grade urothelial carcinoma (HGUC). Original cytological diagnoses were recorded. Results: Fewer cases were given an AUC diagnosis using the PSRUC in comparison to the original diagnoses (26% vs 39%), while the association of AUCs with subsequent HGUC increased from 33% to 53% with the PSRUC. Using the PSRUC resulted in a higher number of low-grade carcinomas assigned to the benign (40%) rather than the AUC (22%) category. The performance of SHGUC/HGUC diagnoses was similar in both systems (predictive value ¼ 94%). Conclusions: The PSRUC seems to improve the performance of urine cytology by limiting the AUC category to cases that are more strongly associated with HGUC. Despite the development of new liquid- and tissuebased ancillary tests, urine cytology remains, along with cystoscopy, an essential diagnostic tool in the screening and surveillance of urothelial carcinoma. Urine cytology, which carries the advantages of being a simple, cost-effective, and noninvasive test that samples the entire urinary tract, has been shown to display a wide range of sensitivity depending on the specimen type, clinical setting, and the grade of urothelial tumors, with higher sensitivity reported for highgrade urothelial carcinoma (HGUC). 1 Urine cytology has also been proven to be a very specific detection tool for HGUC; this high specificity for HGCA represents its most attractive aspect in clinical practice. In that regard, since HGUC cells can shed in the urine, even in carcinomas that are not seen by cystoscopy (ie, occult carcinomas), a positive urine cytology diagnosis is a clinically meaningful result even in the absence of tissue confirmation. 2,3 Consequently, patients with positive cytology and negative cystoscopy or biopsy results are usually investigated further and closely monitored because a significant percentage is eventually proven to harbor HGUC. 4-6 The reporting system for urine cytology has evolved into different stages over time. Initially, Dr Papanicolaou 7 suggested having 5 different cytologic classes based on the level of diagnostic confidence and the nature of the atypical cells. Although this system was reported to be useful in diagnosing HGUC, the diagnostic criteria for each group were unclear. Following the changes in the histopathologic classification of urothelial carcinoma by the World Health Organization/International Society of Urological Pathology in 1998, and in an attempt to standardize the diagnostic 384 Am J Clin Pathol 2016;146: American Society for Clinical Pathology, All rights reserved. For permissions, please journals.permissions@oup.com
2 categories for urine cytology, the Papanicolaou Society of Cytopathology recommended a classification scheme that included an atypical urothelial cell (AUC) category similar to the Bethesda System for reporting cervical cytology. 8,9 This system recommended subclassifying the atypical group into reactive or neoplastic. Although the classification itself was appealing, it suffered from the lack of well-defined criteria for the suggested atypical subcategories. In the recent years, new classification systems with clear criteria have emerged from various institutions from where many institutional well-conducted studies were performed; the results of those studies were, however, difficult to compare due to several factors First, the institutional diagnostic categories differed in their variable inclusion of the suspicious for HGUC diagnosis as well as in their variable subdivision of the AUC category into either AUCs of undetermined significance vs AUCs cannot rule out high-grade carcinoma, AUCs favor a reactive process vs AUCs unclear whether reactive or neoplastic, or AUCs favor a reactive process vs AUCs favor neoplastic. Most important, the criteria used to define the AUC group and subgroups also differed in many aspects, resulting in a wide variation in the rates of AUCs (range, 2%-31%), as well as their association with a subsequent diagnosis of HGUC (range, 8.3%-37.5%). 10,14-18 This significant variation contributed significantly to the desensitization of many urologists to an AUC diagnosis, leading them to frequently consider and treat such AUC cases similarly to negative cases. In this context, the emergence of the newly proposed Paris System for Reporting Urine Cytology (PSRUC) is regarded as a major step toward standardization in both the cytology and urology fields. 19 This international and multiinstitutional achievement is the reflection of a major shift in the understanding of and the approach to urothelial lesions and represents a repositioning of urine cytology in the clinical landscape by focusing on its most clinically relevant aspect, which is the detection of HGUC. Consequently, the four major categories of the PSRUC are negative for HGUC (NHGUC), AUCs, suspicious for SGHUC (SHGUC), and positive for HGUC (HGUC). One important goal of this new system is to transform the AUC category into a reproducible and clinically meaningful category by including mostly cases with cells exhibiting nuclear atypia that is likely to be associated with HGUC; atypia related to low-grade urothelial neoplasms and to various reactive conditions such as polyomavirus infection and urolithiasis are excluded from the AUC category and are rather included in the NHGUC category. In our institution, we have traditionally divided urine cytology results into five categories: negative, atypical cells for which a reactive process is favored (AR), atypical cells that are unclear whether they are reactive or neoplastic (AU), suspicious for SHGUC, and positive for HGUC. 10 While we have recently adopted the PSRUC in our laboratory and we intend to report its performance prospectively, we herein aimed to test the impact of implementing this system by performing a retrospective morphologic analysis using the categories and criteria of the PSRUC in comparison to our previously used system. Materials and Methods In total, 124 consecutive cytologic specimens from the lower urinary tract that had a histologic follow-up within 1 year between 2008 and 2010 were included. The slides were reviewed by one cytopathologist (F.B.) blinded to the outcome and were assigned according to the proposed criteria to one of the four PSRUC categories: NHGUC, AUCs, SHGUC, and HGUC. As suggested by the PSRUC, the NHGUC group included cases that either had benign cytologic features or displayed a mild degree of atypia in a clinical context that is known to induce cytologic changes, such as polyomavirus infection, urolithiasis, irradiation, chemotherapy, and instrumentation Image 1A. Cases with tissue fragments in the absence of cytologic atypia were considered NHGUC, even if they were present in voided specimens. 19,20 Similarly, cells with a nuclear to cytoplasmic (N/C) ratio of more than 0.5 were considered negative if no other abnormal cytologic features were present. The PSRUC AUC diagnosis was reserved for nonsuperficial and nondegenerated urothelial cells with an increased N/C ratio (>0.5) and only one of the following features: nuclear hyperchromasia, irregular nuclear membranes, and irregular coarse clumped chromatin. Atypical degenerated cells were also assigned an AUC diagnosis even if they displayed more than one of the previously mentioned criteria. The PSRUC SHGUC and HGUC cells show similar cytologic characteristics but are differentiated by the number of malignantlooking cells (in general, <10 cells for SHGUC and 10 cells for HGUC). The cells in both categories are nonsuperficial and nondegenerated urothelial cells showing an N/C ratio of more than 0.7, moderate to severe hyperchromasia, and at least one of the two following features: irregular clumpy chromatin or marked irregular nuclear membranes. The initial institution s cytologic diagnoses were also recorded. The original classification and criteria differed with the PSRUC in many aspects. In our original classification, an N/C ratio of more than 0.5 was the defining feature of nuclear atypia, and cells showing this feature were generally assigned to the AUC category, except if the specimen was instrumented and the changes compatible with instrumentation changes or basal cells. The AR category was reserved for atypical cell clusters that showed bubbly American Society for Clinical Pathology Am J Clin Pathol 2016;146: Downloaded 385 from
3 Hassan et al /THE PSRUC AND PERFORMANCE OF CYTOLOGY A B C D Image 1 A, One urothelial cell showing homogeneous, amorphous, ground glass like intranuclear inclusion occupying most of the enlarged nuclear area and a condensed rim of chromatin in keeping with polyomavirus-related changes. The nuclear enlargement is associated with smooth and regular nuclear membranes compared with the irregular nuclear membranes in highgrade malignant cells. This will be categorized under the negative for high-grade urothelial carcinoma category in the new Paris System for Reporting Urine Cytology (PSRUC) (voided specimen, ThinPrep, Papanicolaou, 600). B, A cluster of cells with an increased nuclear to cytoplasmic (N/C) ratio, mild hyperchromasia, fine chromatin, visible nucleoli, and regular nuclear membranes. This case was originally categorized as atypical urothelial cells, favor a reactive process. According to the PSRUC criteria, such cases should be diagnosed as negative for high-grade urothelial carcinoma (voided specimen, ThinPrep, Papanicolaou, 600). C, One degenerated cell displaying a high N/C ratio, nuclear hyperchromasia, intact but irregular nuclear membranes, clumpy chromatin, and a dark India ink chromatin pattern. This case was originally labeled as atypical urothelial cells, unclear if reactive or neoplastic and was classified as atypical urothelial cells according to the PSRUC (voided specimen, ThinPrep, Papanicolaou, 600). D, One single nonsuperficial and nondegenerated urothelial cell showing a high N/C ratio, severe hyperchromasia, and irregular clumpy chromatin pattern. This case was diagnosed as suspicious for high-grade urothelial carcinoma using the PSRUC as well as the original classification (voided specimen, ThinPrep, Papanicolaou, 600). cytoplasm with intact and smooth nuclear membranes, often with conspicuous nucleoli Image 1B. On the other hand, the AU category was used when the urothelial cells, even if single or few in number, appeared to be degenerated but displayed an N/C ratio of more than 0.5 and a dark India ink chromatin pattern with or without irregular nuclear membranes Image 1C. Most cells diagnosed as AU were morphologically similar to the cells that have been termed 386 Am J Clin Pathol 2016;146: American Society for Clinical Pathology 386
4 pseudodegenerated cells by Renshaw. 13 The cytologic features of our original SHGUC and HGUC categories were close to those adopted in the PSRUC, with 10 cells being the differentiating quantitative cutoff Image 1D. The only difference is that cellular degeneration was not an exclusion criterion from the original SHGUC group, and a portion of cases in this category included degenerated cells. The original and revised categories were both correlated with the histologic outcome, which was divided into benign, low-grade neoplasms (LGNs) including papilloma, papillary neoplasm of low-malignant potential and low-grade urothelial carcinoma, and HGUC including noninvasive high-grade papillary urothelial carcinoma, invasive urothelial carcinoma, and urothelial carcinoma in situ. When more than one cytologic specimen existed in a cytohistologic follow-up and correlation, the worst was used as representative of the group for the cytologic-histologic correlation as long as it was rendered within 1 year preceding the follow-up biopsy. The chosen interval of 1 year between cytology and biopsy was considered the most valid by urologists in our institution. Longer intervals may contaminate the study results as they theoretically allow new unrelated tumors to develop during the follow-up (ie, tumors potentially absent when the index cytologic specimen was taken). 1 Results The median age was 73.8 years, and the male to female ratio was 4:1.66 patients (53.2%) who were under surveillance following a diagnosis of urothelial neoplasia, while 58 (46.8%) patients were evaluated for new urologic symptoms, including hematuria. Ninety-eight (79%) specimens were voided, and 21% were instrumented. Voided specimens were ThinPrep (Hologic, Marlborough, MA) samples and consisted of one slide each, while instrumented specimens were prepared using conventional techniques (smears or cytospins) and consisted of one to two slides each. The cytologic results and histologic correlations are shown in Table 1 and Table 2. The follow-up biopsy results were as follows: benign in 30 (24%), LGNs in 25 (20%), and HGUC in 69 (56%) patients. In comparison to the original system, using the PSRUC resulted in significantly fewer cases being assigned to the AUC cytologic category (39% vs 26%). Inversely, more cases were diagnosed as negative on cytology (36% of cases) using the PSRUC in comparison to the original system, in which only 22% were considered negative. In comparison, no significant change was noted in the rate of SHGUC/HGUC using the original system and the PSRUC (40% vs 38%, respectively). There was an important difference in the performance of the AUC category between the two systems; while 33% of AUC cases were associated with a subsequent histologic diagnosis of HGUC using the original system, this rate increased to 53% using the PSRUC. Also, using the PSRUC, 72% of cases that were subsequently diagnosed as LGUC fell in the NHGUC category, while the rate was only 28% using the original system, in which most (72%) of histologically proven LGUCs were initially diagnosed as atypical on cytology. Moreover, there was no change in the performance of an SHGUC/HGUC diagnoses using the two systems, and the predictive value for subsequent HGUC was 94%. Importantly, applying the PSRUC resulted in a sharper demarcation in the predictive values of different cytologic categories in comparison to the original system; indeed, while the rates of subsequent HGUC using the original system were 26%, 33%, 91%, and 96%, respectively, following a cytologic diagnosis of benign, AUCs, SHGUC, and HGUC, the rates were 15%, 53%, 83%, and 100%, respectively, using the PSRUC criteria. Discussion The current study demonstrates that implementing the PSRUC improved overall performance of urine cytology in several aspects. Most important was the fact that using this system not only resulted in fewer cases being assigned to the AUC category but that the association of an AUC diagnosis with subsequent HGUC increased significantly from Table 1 Correlation Between Cytology and Histology Results Within 1 Year Using the Paris System for Reporting Urine Cytology a Cytology Histology NGHUC (n ¼ 45, 36%) AUCs (n ¼ 32, 26%) SHGUC (n ¼ 18, 15%) HGUC (n ¼ 29, 23%) Benign LGN HGUC PPV for HGUC, % AUCs, atypical urothelial cells; HGUC, high-grade urothelial carcinoma; LGN, low-grade neoplasia; NHGUC, negative for high-grade urothelial carcinoma; PPV, positive predictive value; SHGUC, suspicious for high-grade urothelial carcinoma. a Values are presented as numbers unless otherwise indicated. American Society for Clinical Pathology Am J Clin Pathol 2016;146: Downloaded 387 from
5 Hassan et al /THE PSRUC AND PERFORMANCE OF CYTOLOGY Table 2 Correlation Between Cytology and Histology Results Within 1 Year Using the Original System a Cytology Histology NGHUC (n ¼ 27, 22%) AUCs (AR þ AU) (n ¼ 48, 39%) SHGUC (n ¼ 23, 19%) HGUC (n ¼ 26, 21%) Benign LGN HGUC PPV for HGUC, % AR, atypical cells for which a reactive process is favored; AU, atypical cells that are unclear whether they are reactive or neoplastic; AUCs, atypical urothelial cells; HGUC, high-grade urothelial carcinoma; LGN, low-grade urothelial neoplasia; NHGUC, negative for high-grade urothelial carcinoma; PPV, positive predictive value; SHGUC, suspicious for high-grade urothelial carcinoma. a Values are presented as numbers unless otherwise indicated. 33% to 53%. Those promising results may be explained by the following facts: while our previous definition of atypia was simply a cell with an N/C ratio of more than 0.5 after excluding instrumentation artifact and basal cells, the PSRUC requires additional cytologic features to define the cell as atypical, such as hyperchromasia, irregular nuclear membranes, or clumpy chromatin pattern. 19 As such, cases falling in our previous definition of atypical, favor reactive can be essentially diagnosed as NHGUC using the new classification system. Also, while the PSRUC considers all cases with cells showing changes typical of polyomavirus infection as NHGUC regardless of the clinical context, we have traditionally included such cases under the atypical, unclear category in the absence of a history of immunosuppression and/or transplantation. To limit the diagnosis of AUCs to the strict minimum, the PSRUC has also recommended diagnosing cell clusters or tissue fragments as NHGUC provided cytologic atypia is lacking, an approach that we have already been practicing in the past and that is therefore unrelated to the observed change in the rate of atypia in our cohort. 20 The second impact was the higher frequency of cases with subsequent LGNs assigned to the NHGUC category. In that regard, older studies have attempted to characterize the cytologic features of low-grade urothelial carcinoma, and criteria such as an N/C ratio of more than 0.5, mild hyperchromasia, nuclear grooves, and mildly irregular nuclear membranes were proposed However, the presence of cytologic overlap between low-grade urothelial carcinoma and reactive changes, the reported low sensitivity, and low interobserver agreement for diagnosing low-grade urothelial carcinoma, in addition to the fact that the detection of HGUC became the only significant clinical role for urinary cytology, have shifted the cytologic criteria toward detecting HGUC in more contemporary cytology classifications, particularly in the PSRUC. 13,24,25 In fact, following the new criteria, the only instance in which a definitive diagnosis of low-grade urothelial carcinoma can be rendered is in the presence of cellular fragments with fibrovascular cores, with cells displaying a mild degree of atypia falling short of an HGUC diagnosis, a scenario of extreme rarity in routine clinical practice. Of note, the recommended term for such cases in the PSRUC is low-grade urothelial neoplasia, a term that encompasses low-grade urothelial carcinoma, papillary urothelial neoplasm of low malignant potential, and papilloma. 19 Our results also suggest that the quantitative criteria adopted by the PSRUC to differentiate the SHGUC and HGUC categories are valid, as reflected in their distinct predictive values for subsequent detection of HGUC. Of note is that this quantitative approach was based on five studies preceding the publication of the PSRUC, in which the number of atypical urothelial cells was used and indirectly validated as being prognostically significant. In the first study, Piaton et al 11,17 recommended dividing the AUC categories into two groups: AUC of undetermined significance, or AUC-US and AUC, cannot exclude high-grade carcinoma, or AUC-H, in a division that echoes the Bethesda System for reporting gynecologic cytology. 26 In the classification by Piaton et al, the criteria used to define AUC-H correspond to a large extent to those used in the SHGUC category of the PSRUC. Quantitative criteria were also required, and the diagnosis was restricted to cases with severely abnormal urothelial cells that were few in number, generally less than Similarly, our group has been using the SHGUC category by applying morphologic and quantitative criteria comparable to the AUC-H category used by Piaton et al and by using the 10-cell cutoff to distinguish a SHGUC from an HGUC diagnosis. Using those criteria in a retrospective study in which the original diagnoses were retrieved, we have previously reported different associations of the SHGUC and HGUC categories with subsequent HGUC (80% vs 90%). 27 In a subsequent study of 112 cases in which the slides were systematically reexamined and the number of atypical cells counted, we were also able to demonstrate that cases with one to five atypical cells were equally associated with subsequent HGUC compared with those having five to 10 atypical cells (predictive value of 58%), but the association with subsequent HGUC rose to 77% in the presence of more than 10 atypical cells. 28 In a 388 Am J Clin Pathol 2016;146: American Society for Clinical Pathology 388
6 similar study in which the AUC category was explored, McCroskey et al 29 reported that the average number of atypical cells differed depending on the follow-up results, with the group of patients having a negative follow-up harboring a smaller average number of atypical cells per slide than those with a subsequent diagnosis of HGUC (nine vs 16 cells, respectively). Incorporating the findings of the current study with those of the literature not only indicate that the quantitative criteria proposed in the PSRUC are valid but also point to the fact that the suspicious and positive categories are distinct and should probably not be lumped together at the cytologic and clinical levels. This quantitative approach is not unprecedented and has also been validated in other systems, especially in the Bethesda System of gynecologic cytology, in which the main difference between ASC- H and high-grade squamous intraepithelial lesion is the number of atypical cells. 26 The study is limited by its retrospective nature and the fact that we only included cases with a histologic follow-up. Therefore, the reported percentages of different PSRUC categories are not representative of all urine cytology specimens seen in our laboratory, since most patients do not undergo a follow-up biopsy. Another limiting factor that needs to be taken into account when interpreting the results of the current study is that the original diagnoses were made by several cytopathologists, while the PSRUC criteria were applied by one author who was a member of the working groups of the PSRUC and consequently was familiar with the proposed criteria. Therefore, whether interobserver diagnostic variability between the department s cytopathologists could have also played a role in the weaker performance of the original system cannot totally be excluded. As is the case following the introduction of any newly proposed system, it is anticipated that an adaptation period preferably with reference image banks and reproducibility studies will be needed before different groups (and even different cytopathologists within the same group) reach comparable diagnostic thresholds, especially in the AUC and SHGUC categories, and before the validity of the new system can be accurately tested in clinical practice. As such, the results of the current study are considered preliminary and need to be prospectively validated. In summary, the PSRUC seems to improve the performance of urine cytology by decreasing the number of cases assigned to the AUC category and by improving its predictive accuracy for a subsequent histologic diagnosis of HGUC. Corresponding author: Fadi Brimo, MD, Dept of Pathology, McGill University, 1001 Decarie Blvd. Montreal, Quebec, H4A 3J1, Canada; fadi.brimo@mcgill.ca. References 1. Bastacky S, Ibrahim S, Wilczynski SP, et al. The accuracy of urinary cytology in daily practice. Cancer. 1999;87: Karakiewicz PI, Benayoun S, Zippe C, et al. Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder. BJU Int. 2006;97: Ramakumar S, Bhuiyan J, Besse JA, et al. Comparison of screening methods in the detection of bladder cancer. J Urol. 1999;161: Raitanen MP, Aine RA, Kaasinen ES, et al. Suspicious urine cytology (class III) in patients with bladder cancer: should it be considered as negative or positive? Scand J Urol Nephrol. 2002;36: Wiener HG, Vooijs GP, van t Hof-Grootenboer B. Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer. Acta Cytol. 1993;37: Yafi FA, Brimo F, Auger M, et al. Is the performance of urinary cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer. Urol Oncol. 2014;32:e21-e Papanicolaou GN. Cytology of the urine sediment in neoplasms of the urinary tract. J Urol. 1947;57: Epstein JI, Amin MB, Reuter VR, et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol. 1998;22: Layfield LJ, Elsheikh TM, Fili A, et al. Papanicolaou society of C. Review of the state of the art and recommendations of the Papanicolaou Society of Cytopathology for Urinary Cytology Procedures and Reporting: the Papanicolaou Society of Cytopathology Practice Guidelines Task Force. Diagn Cytopathol. 2004;30: Brimo F, Vollmer RT, Case B, et al. Accuracy of urine cytology and the significance of an atypical category. Am J Clin Pathol. 2009;132: Piaton E, Advenier AS, Benaim G, et al. Atypical urothelial cells (AUC): a Bethesda-derived wording applicable to urinary cytopathology. Ann Pathol. 2011;31: Rosenthal DL, Vandenbussche CJ, Burroughs FH, et al. The Johns Hopkins Hospital template for urologic cytology samples, part I: creating the template. Cancer Cytopathol. 2013;121: Renshaw AA. Subclassifying atypical urinary cytology specimens. Cancer. 2000;90: Bhatia A, Dey P, Kakkar N, et al. Malignant atypical cell in urine cytology: a diagnostic dilemma. Cytojournal. 2006;3: Mokhtar GA, Al-Dousari M, Al-Ghamedi D. Diagnostic significance of atypical category in the voided urine samples: a retrospective study in a tertiary care center. Urol Ann. 2010;2: Muus Ubago J, Mehta V, Wojcik EM, et al. Evaluation of atypical urine cytology progression to malignancy. Cancer Cytopathol. 2013;121: Piaton E, Decaussin-Petrucci M, Mege-Lechevallier F, et al. Diagnostic terminology for urinary cytology reports including the new subcategories atypical urothelial cells of undetermined significance (AUC-US) and cannot exclude high grade (AUC-H). Cytopathology. 2014;25: American Society for Clinical Pathology Am J Clin Pathol 2016;146: Downloaded 389 from
7 Hassan et al /THE PSRUC AND PERFORMANCE OF CYTOLOGY 18. VandenBussche CJ, Sathiyamoorthy S, Owens CL, et al. The Johns Hopkins Hospital template for urologic cytology samples, parts II and III: improving the predictability of indeterminate results in urinary cytologic samples: an outcomes and cytomorphologic study. Cancer Cytopathol. 2013;121: Rosenthal DL, Wojcik Eva M, et al. The Paris System for Reporting Urinary Cytology. New York, NY: Springer; Onur I, Rosenthal DL, VandenBussche CJ. Benign-appearing urothelial tissue fragments in noninstrumented voided urine specimens are associated with low rates of urothelial neoplasia. Cancer Cytopathol. 2015;123: Murphy WM, Soloway MS, Jukkola AF, et al. Urinary cytology and bladder cancer: the cellular features of transitional cell neoplasms. Cancer. 1984;53: Raab SS, Lenel JC, Cohen MB. Low grade transitional cell carcinoma of the bladder: cytologic diagnosis by key features as identified by logistic regression analysis. Cancer. 1994;74: Raab SS, Slagel DD, Jensen CS, et al. Low-grade transitional cell carcinoma of the urinary bladder: application of select cytologic criteria to improve diagnostic accuracy [corrected]. Mod Pathol. 1996;9: Reid MD, Osunkoya AO, Siddiqui MT, et al. Accuracy of grading of urothelial carcinoma on urine cytology: an analysis of interobserver and intraobserver agreement. Int J Clin Exp Pathol. 2012;5: Renshaw AA, Nappi D, Weinberg DS. Cytology of grade 1 papillary transitional cell carcinoma: a comparison of cytologic, architectural and morphometric criteria in cystoscopically obtained urine. Acta Cytol. 1996;40: Nayar RWD. The Bethesda System for Reporting Cervical Cytology. 3rd ed. New York, NY: Springer; Ton Nu TN, Kassouf W, Ahmadi-Kaliji B, et al. The value of the suspicious for urothelial carcinoma cytology category: a correlative study of 4 years including 337 patients. Cancer Cytopathol. 2014;122: Brimo FXB, Kassouf W, Ahmadi-Khaliji B, et al. Urine cytology: does the number of atypical urothelial cells matter? A qualitative and quantitative study of 112 cases. J Am Soc Cytopathol. 2015;4: McCroskey ZBB, Hu Z, Wocjik E, et al. Subclassifying atypia in urine cytology: what are the helpful features? J Am Soc Cytopathol. 2015;4: Am J Clin Pathol 2016;146: American Society for Clinical Pathology 390
Accuracy of Urine Cytology and the Significance of an Atypical Category
Anatomic Pathology / Significance of an Atypical Urothelial Category Accuracy of Urine Cytology and the Significance of an Atypical Category Fadi Brimo, MD, 1 Robin T. Vollmer, MD, 2 Bruce Case, MD, 1
More informationThe application of cytology in urological diseases
Voided urine cytology The application of cytology in urological diseases Dr Ashish Chandra FRCPath DipRCPath (Cytol) Guy s & St Thomas NHSfT London Detection of high grade urothelial carcinoma Monitoring
More informationUrinary Cytology. Spasenija Savic Prince, MD Pathology, University Hospital Basel, Switzerland
Urinary Cytology Spasenija Savic Prince, MD Pathology, University Hospital Basel, Switzerland Outline Pre-analytics The Paris System (TPS): Background Diagnostic categories Morphologic criteria for each
More informationRationale of The Paris System for Reporting Urinary Cytopathology: The NEW paradigm
Rationale of The Paris System for Reporting Urinary Cytopathology: The NEW paradigm Eva M. Wojcik, MD Professor and Chair of Pathology Professor of Urology Loyola University, Chicago, Il Why to standardize
More informationToyonori Tsuzuki MD, PhD Professor and Chair Department of Surgical Pathology Aichi Medical University Hospital
29th European Congress of Pathology (ECP 2017) Amsterdam RAI. The Paris System for Reporting Urinary Cytology: The Concept and Management Toyonori Tsuzuki MD, PhD Professor and Chair Aichi Medical University
More informationAfterword: The Paris System for Reporting Urinary Cytology
Afterword: The Paris System for Reporting Urinary Cytology Dorothy L. Rosenthal, Eva M. Wojcik, and Daniel F.I. Kurtycz The primary goal of The Paris System Working Group was standardizing the terminology
More informationTransitional Cell Carcinoma of the Renal Pelvis The Diagnostic Role of Pelvic Washings
Anatomic Pathology / TRANSITIONAL CELL CARCINOMA OF THE RENAL PELVIS Transitional Cell Carcinoma of the Renal Pelvis The Diagnostic Role of Pelvic Washings Deborah Witte, MD, Luan D. Truong, MD, and Ibrahim
More informationUrinary Cytology. Spasenija Savic Prince Pathology, University Hospital Basel, Switzerland
Urinary Cytology Spasenija Savic Prince Pathology, University Hospital Basel, Switzerland Outline Pre-analytics The Paris System (TPS): Background Diagnostic categories Morphologic criteria for each category
More informationUsefulness of Diagnostic Qualifiers for Thyroid Fine-Needle Aspirations With Atypia of Undetermined Significance
Anatomic Pathology / AUS Qualifiers in Thyroid FNAs Usefulness of Diagnostic Qualifiers for Thyroid Fine-Needle Aspirations With Atypia of Undetermined Significance Paul A. VanderLaan, MD, PhD, 1 Ellen
More informationPredictors of Malignancy in Thyroid Fine-Needle Aspirates Cyst Fluid Only Cases
Predictors of Malignancy in Thyroid Fine-Needle Aspirates Cyst Fluid Only Cases Can Potential Clues of Malignancy Be Identified? Mohammad Jaragh, MD 1 ; V. Bessie Carydis, MMedSci (Cytol) 1 ; Christina
More informationApplication of Urovision FISH testing for diagnosis of bladder cancer
Application of Urovision FISH testing for diagnosis of bladder cancer Eva M. Wojcik, MD Chair and Professor of Pathology and Urology Loyola University, Chicago, USA Bladder cancer - current status ~ 76,900
More informationThyroid Cytopathology: Weighing In The Bethesda System
Thyroid Cytopathology: Weighing In The Bethesda System V8 Conflicts No financial consideration Bias Work in the Canadian environment where litigation is less Thyroid cytology is often referred in by small
More informationClinical Outcome for Atypia of Undetermined Significance in Thyroid Fine-Needle Aspirations Should Repeated FNA Be the Preferred Initial Approach?
Anatomic Pathology / Clinical Outcome for AUS Thyroid FNA Clinical Outcome for Atypia of Undetermined Significance in Thyroid Fine-Needle Aspirations Should Repeated FNA Be the Preferred Initial Approach?
More informationEvaluation of Low-Grade Squamous Intraepithelial Lesions, Cannot Exclude High-Grade Squamous Intraepithelial Lesions on Cervical Smear
The Korean Journal of Pathology 2010; 44: 528-35 DOI: 10.4132/KoreanJPathol.2010.44.5.528 Evaluation of Low-Grade Squamous Intraepithelial Lesions, Cannot Exclude High-Grade Squamous Intraepithelial Lesions
More informationThyroid Nodules: Understanding FNA Cytology (The Bethesda System for Reporting of Thyroid Cytopathology) Shamlal Mangray, MB, BS
Thyroid Nodules: Understanding FNA Cytology (The Bethesda System for Reporting of Thyroid Cytopathology) Shamlal Mangray, MB, BS Attending Pathologist Rhode Island Hospital, Providence, RI DISCLOSURE:
More informationSalivary Gland Cytology: A Clinical Approach to Diagnosis and Management of Atypical and Suspicious Lesions
Salivary Gland Cytology: A Clinical Approach to Diagnosis and Management of Atypical and Suspicious Lesions W.C. Faquin, M.D., Ph.D. Massachusetts General Hospital Harvard Medical School, USA Marc Pusztaszeri,
More informationCombining Color and Morphology Improves Identification of Low-Grade Urothelial Cancer Cells
Combining Color and Morphology Improves Identification of Low-Grade Urothelial Cancer Cells Alexander Shtabsky 1, Sylvia Lew 2, Ronny Rona 3, Noa Davis 4, Yoram Mor 5, Uri Lindner 6, Ofer Nativ 7, Ofer
More informationNormal Morphology. Anatomic Considerations. Normal Urothelial Histology and Cytology
1 Normal Morphology Anatomic Considerations The urinary tract can be divided into three regions: the kidney; the calyces, pelves and ureters (upper collecting system or upper tract); and the bladder and
More informationPotential Pitfalls for False Suspicion of Papillary Thyroid Carcinoma:
SUPPLEMENT 1 SPECIAL ISSUE: CYTOPATHOLOGY OF THE THYROID GLAND Guest Editor: Zubair Baloch Potential Pitfalls for False Suspicion of Papillary Thyroid Carcinoma: A Cytohistologic Review of 22 Cases Xin
More informationObjectives. Atypical Glandular Cells. Atypical Endocervical Cells. Reactive Endocervical Cells
2013 California Society of Pathologists 66 th Annual Meeting San Francisco, CA Atypical Glandular Cells to Early Invasive Adenocarcinoma: Cervical Cytology and Histology Christina S. Kong, MD Associate
More informationCytopathological evaluation of various thyroid lesions based on Bethesda system for reporting thyroid lesions
International Journal of Research in Medical Sciences Khadatkar AS et al. Int J Res Med Sci. 2017 Apr;5(4):1339-1343 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Original Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20170901
More informationDIAGNOSIS AND REPORTING OF FOLLICULAR-PATTERNED THYROID LESIONS BY FINE NEEDLE ASPIRATION
Follicular-patterned thyroid lesions, WC Faquin 1 DIAGNOSIS AND REPORTING OF FOLLICULAR-PATTERNED THYROID LESIONS BY FINE NEEDLE ASPIRATION William C. Faquin, M.D., Ph.D Department of Pathology, Massachusetts
More information형태계측학적분석과 ThinPrep 액상소변세포검사를이용한악성요로상피세포검출
원저 대한세포병리학회지 ISSN 1017-0391 10.3338/kjc.2008.19.2.136 형태계측학적분석과 ThinPrep 액상소변세포검사를이용한악성요로상피세포검출 고려대학교구로병원병리과, 1 고려대학교구로병원동결폐조직은행 2 신봉경 1,2 이영석 1 정회선 1,2 이상호 1,2 김현철 1 김애리 1,2 김인선 1 김한겸 1,2 Detecting Malignant
More informationThyroid follicular neoplasms in cytology. Ulrika Klopčič Institute of Oncology, Department of Cytopathology, Ljubljana, Slovenia
Thyroid follicular neoplasms in cytology Ulrika Klopčič Institute of Oncology, Department of Cytopathology, Ljubljana, Slovenia Lecture overview importance of FNAB in assessing thyroid lesions follicular
More informationAward Top Quizzes For Residents
Award Top Quizzes For Residents Giovanni Negri, MD, Bolzano (Italy) Eva M. Wojcik MD, Department of Pathology, Loyola University, Chicago (USA) Esther D. Rossi MD, PhD, MIAC, Division of Anatomic Pathology
More information"Atypical": Criteria and
"Atypical": Criteria and Controversies Esther Rossi MD PhD MIAC Division of Anatomic Pathology and Cytology Catholic University of Sacred Heart Rome, Italy CASE HISTORY In 2015, 45 y/o woman underwent
More informationACCME/Disclosures. Cribriform Lesions of the Prostate. Case
Cribriform Lesions of the Prostate Ming Zhou, MD, PhD Departments of Pathology and Urology New York University Langone Medical Center New York, NY Ming.Zhou@NYUMC.ORG ACCME/Disclosures The USCAP requires
More informationCellular Dyscohesion in Fine-Needle Aspiration of Breast Carcinoma Prognostic Indicator for Axillary Lymph Node Metastases?
natomic Pathology / PROGNOSTIC INDICTOR FOR XILLRY LYMPH NODE METSTSES Cellular Dyscohesion in Fine-Needle spiration of reast Carcinoma Prognostic Indicator for xillary Lymph Node Metastases? nne. Schiller,
More informationClinical Practice Guidelines June 2013
Clinical Practice Guidelines June 2013 General Principles: The Papanicolaou (Pap) smear is widely credited with reducing mortality from cervical cancer, and remains the single best method for the early
More informationMEDICAL POLICY SUBJECT: URINARY TUMOR MARKERS FOR BLADDER CANCER. POLICY NUMBER: CATEGORY: Technology Assessment
MEDICAL POLICY SUBJECT: URINARY TUMOR MARKERS FOR PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including
More informationA novel urine cytology stain for the detection and monitoring of urothelial carcinoma
A novel urine cytology stain for the detection and monitoring of urothelial carcinoma Ofer Yossepovitch 1, Yoram Mor 2, Uri Lindner 3, Ofer Nativ 4, Ofer Gofrit 5, Ilan Leibovitch 6, Haim Matzkin 7, Ami
More informationPAP SMEAR by Dr.Shantha Krishnamurthy MD Senior Consultant Pathology Fortis Hospitals
PAP SMEAR by Dr.Shantha Krishnamurthy MD Senior Consultant Pathology Fortis Hospitals Historical Named after George Papanicolaou, a Greek American Studied cervical epithelium in menstrual cycle of guinea
More informationURINE CYTOLOGY. Richard Doughty Avd for patologi Ahus
URINE CYTOLOGY Richard Doughty Avd for patologi Ahus The main purpose of urine cytology is To detect High Grade Urothelial Carcinoma Outline Urine the basics A little on the history of claasification
More informationAtypia in Diagnostic Cytopathology: Strategies to Reduce Overuse A CQI initiative
in Diagnostic Cytopathology: Strategies to Reduce Overuse A CQI initiative Dr. Mariamma Joseph and Susan McRae Objectives Review cytology literature on standardization of as a diagnostic term Address the
More informationPancreatic malignant tumors are the fifth leading cause of cancerrelated
44 CANCER CYTOPATHOLOGY Cytologic Criteria for Well Differentiated Adenocarcinoma of the Pancreas in Fine-Needle Aspiration Biopsy Specimens Fan Lin, M.D., Ph.D. 1 Gregg Staerkel, M.D. 2 1 Department of
More informationDecember 22, Earl Berman, MD Attn Medical Review Two Vantage Way Nashville, TN
December 22, 2016 Earl Berman, MD Attn Medical Review Two Vantage Way Nashville, TN 37228 cmd.inquiry@cgsadmin.com Re: Draft Local Coverage Determination - Bladder Tumor Markers (DL36975) Dear Dr. Berman:
More informationGynecologic Cytopathology: Glandular lesions
Gynecologic Cytopathology: Glandular lesions Lin Wai Fung (MSc, MPH, CMIAC) 17/4/2014 Glandular lesions of the uterus Endocervix Endometrium Normal endocervical cells Sheets, strips well-preserved architecture:
More informationUpdate on Thyroid FNA The Bethesda System. Shikha Bose M.D. Associate Professor Cedars Sinai Medical Center
Update on Thyroid FNA The Bethesda System Shikha Bose M.D. Associate Professor Cedars Sinai Medical Center Thyroid Nodules Frequent occurrence Palpable: 4-7% of adults Ultrasound: 10-31% Majority benign
More informationIntraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance
& 2006 USCAP, Inc All rights reserved 0893-3952/06 $30.00 www.modernpathology.org Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance Charles C Guo 1 and
More informationBOSNIAN-TURKISH CYTOPATHOLOGY SCHOOL June 18-19, 2016 Sarajevo. Case Discussions. 60 year old woman Routine gynecologic control LBC
BOSNIAN-TURKISH CYTOPATHOLOGY SCHOOL June 18-19, 2016 Sarajevo Case Discussions Prof Dr Sıtkı Tuzlalı Tuzlalı Pathology Laboratory 60 year old woman Routine gynecologic control LBC 1 2 Endometrial thickening
More informationIndex 179. Genital tract contaminants, 17, 20, 22, 150 papilloma virus-infected cells, 47 squamous cells, sources of, 7
Index Accuracy of urinary cytology, 166 Acute inflammatory cells, 38 catheter sample, 39 herpes simplex infections, 44 carcinomas, 104, 105 non-viral inclusions, 52, 53 voided urine, 17 Adenocarcinoma
More informationApplying Risk Management Principles to QA in Surgical Pathology: From Principles to Practice
Applying Risk Management Principles to QA in Surgical Pathology: From Principles to Practice Dr. Gregory Flynn CEO, Institute for Quality Management in Healthcare Managing Director, Quality Management
More informationWorkshop for O& G trainees and paramedics 17 Dec 2011 Cytological Interpretation
Workshop for O& G trainees and paramedics 17 Dec 2011 Cytological Interpretation May Yu Director of Cytology Laboratory Service Department of Anatomical & Cellular Pathology Prince of Wales Hospital Cervical
More informationRepeat Thyroid Nodule Fine-Needle Aspiration in Patients With Initial Benign Cytologic Results
Anatomic Pathology / REPEAT THYROID FINE-NEEDLE ASPIRATION Repeat Thyroid Nodule Fine-Needle Aspiration in Patients With Initial Benign Cytologic Results Melina B. Flanagan, MD, MSPH, 1 N. Paul Ohori,
More informationHANDOUT. Bile Duct Brushing Cytology: A Morphologic and Molecular Approach
HANDOUT Bile Duct Brushing Cytology: A Morphologic and Molecular Approach Lester J. Layfield, M.D. Professor and Chair Department of Pathology & Anatomical Sciences University of Missouri Introduction
More informationNIFTP Cytologic Aspects
NIFTP Cytologic Aspects William C. Faquin, MD PhD Director, Head and Neck Pathology Massachusetts General Hospital & Massachusetts Eye and Ear Infirmary Boston, MA USA So, what is the story about FVPTC
More informationCytology Report Format
Squamous Precursor Lesions and Malignancies In Pap Test Dina R. Mody, MD, FCAP Director of Cytology The Methodist Hospital, Houston, TX Professor of Pathology and Laboratory Medicine Weill Medical College
More informationCytyc Corporation - Case Presentation Archive - March 2002
FirstCyte Ductal Lavage History: 68 Year Old Female Gail Index: Unknown Clinical History: Negative Mammogram in 1995 6 yrs. later presents with bloody nipple discharge Subsequent suspicious mammogram Suspicious
More informationInternational Society of Gynecological Pathologists Symposium 2007
International Society of Gynecological Pathologists Symposium 2007 Anais Malpica, M.D. Department of Pathology The University of Texas M.D. Anderson Cancer Center Grading of Ovarian Cancer Histologic grade
More informationSQUAMOUS CELLS: Atypical squamous cells (ASC) - of undetermined significance (ASC-US) - cannot exclude HSIL (ASC-H)
SQUAMOUS CELLS: Atypical squamous cells (ASC) - of undetermined significance (ASC-US) - cannot exclude HSIL (ASC-H) ASC refers to cytologic changes suggestive of SIL, which are qualitativley or quantitatively
More informationIntroduction. Key Words: high-grade prostatic intraepithelial neoplasia, HGPIN, radical prostatectomy, prostate biopsy, insignificant prostate cancer
Prostate cancer after initial high-grade prostatic intraepithelial neoplasia and benign prostate biopsy Premal Patel, MD, 1 Jasmir G. Nayak, MD, 1,2 Zlatica Biljetina, MD, 4 Bryan Donnelly, MD 3, Kiril
More informationPalpable Breast Lesions Cytomorphological Analysis and Scoring System with Histopatholgical Correlation
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 10 Ver. III (October. 2016), PP 25-29 www.iosrjournals.org Palpable Breast Lesions Cytomorphological
More informationGlandular lesions in cervical cytology. Margareta Strojan Fležar Institute of Pathology Faculty of Medicine University of Ljubljana Slovenia
Glandular lesions in cervical cytology Margareta Strojan Fležar Institute of Pathology Faculty of Medicine University of Ljubljana Slovenia 2nd PANNONIA CONGRESS OF PATHOLOGY, SIÓFOK, HUNGARY, 17-19 MAY
More informationEnterprise Interest None
Enterprise Interest None Risk stratification of salivary gland lesions on cytology based on the proposed Milan System for reporting salivary gland cytopathology: A pilot study Kartik Viswanathan, M.D.,
More informationA Comparison Between ThinPrep Monolayer and Cytospin Cytology for the Detection of Bladder Cancer
www.kjurology.org http://dx.doi.org/10.4111/kju.2014.55.6.390 Original Article - Urological Oncology http://crossmark.crossref.org/dialog/?doi=10.4111/kju.2014.55.6.390&domain=pdf&date_stamp=2014-06-16
More informationCase # year old man with a 2 cm right kidney mass
Case # 4. 52 year old man with a 2 cm right kidney mass Figure 1 Figure 2 Figure 3 Figure 4 Diagnosis: Negative/Non-diagnostic Normal kidney tissue Fine needle aspiration (FNA) of the kidney is performed
More informationLong-Term Outcome and Relative Risk in Women With Atypical Squamous Cells of Undetermined Significance
Anatomic Pathology / LONG-TERM OUTCOME WITH ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE Long-Term Outcome and Relative Risk in Women With Atypical Squamous Cells of Undetermined Significance Stephen
More informationCytology of gastrointestinal (GI) samples has a high
Comparison of ThinPrep Preparations to Other Preparation Types in Gastrointestinal Cytology Observations From the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytology
More informationSPECIMEN PREPARATION AND ADEQUACY OF THE MATERIAL
SPECIMEN PREPARATION AND ADEQUACY OF THE MATERIAL Guido FADDA, MD, MIAC Head, Cytopathology Section Department of Anatomic Pathology and Laboratory Medicine Agostino Gemelli School of Medicine and Hospital
More informationAn audit of liquid-based cervical cytology screening samples (ThinPrep and SurePath) reported as glandular neoplasia
DOI:10.1111/j.1365-2303.2009.00695.x An audit of liquid-based cervical cytology screening samples (ThinPrep and SurePath) reported as glandular neoplasia S. A. Thiryayi, J. Marshall and D. N. Rana Manchester
More informationHyperchromatic Crowded Groups: What is Your Diagnosis? Session 3000
Hyperchromatic Crowded Groups: What is Your Diagnosis? Session 3000 Thomas A. Bonfiglio, M.D. Professor Emeritus, Pathology and Laboratory Medicine University of Rochester Disclosures In the past 12 months,
More informationComparison of Thyroid Fine-Needle Aspiration and Core Needle Biopsy
Anatomic Pathology / THYROID FNA AND CORE NEEDLE BIOPSY Comparison of Thyroid Fine-Needle Aspiration and Core Needle Biopsy Andrew A. Renshaw, MD, 1 and Nat Pinnar, MD 2 Key Words: Thyroid; Neoplasia;
More informationThe Korean Journal of Cytopathology 13(1): 14-20, 2002
13 1 The Korean Journal of Cytopathology 13(1): 14-20, 2002 : ASCUS 1941 Papanicolaou. The Bethesda System(TBS) 1) 1988, atypical squamous cells of undetermined significance(ascus), low-grade squamous
More informationThe diagnostic category of atypical squamous cells of undetermined
100 CANCER CYTOPATHOLOGY Significance of a Diagnosis of Atypical Squamous Cells of Undetermined Significance for Papanicolaou Smears in Perimenopausal and Postmenopausal Women Jeffrey T. Keating, M.D.
More informationBiliary Tract Neoplasia: A Cyto-histologic Review. Michelle Reid, MD, MSc Professor of Pathology Director of Cytopathology Emory University Hospital
Biliary Tract Neoplasia: A Cyto-histologic Review Michelle Reid, MD, MSc Professor of Pathology Director of Cytopathology Emory University Hospital Bile Duct Brushings (BDB) BDBs are the initial diagnostic
More informationROBINSON CYTOLOGICAL GRADING OF BREAST CARCINOMA ON FINE NEEDLE ASPIRATION CYTOLOGY- AN OVERVIEW
Page564 Research Article Biological Sciences ROBINSON CYTOLOGICAL GRADING OF BREAST CARCINOMA ON FINE NEEDLE ASPIRATION CYTOLOGY- AN OVERVIEW Charusheela Rajesh Gore, Chandanwale Shirish S, Ruchika Aggarwal,
More informationKyle C. Strickland, MD, PhD; Brooke E. Howitt, MD; Justine A. Barletta, MD; Edmund S. Cibas, MD Jeffrey F. Krane, MD, PhD
Suggesting the Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features (NIFTP): A Retrospective Analysis of Atypical and Suspicious Nodules Kyle C. Strickland,
More informationSuspicious Cytologic Diagnostic Category in Endoscopic Ultrasound-Guided FNA of the Pancreas: Follow-Up and Outcomes
Suspicious Cytologic Diagnostic Category in Endoscopic Ultrasound-Guided FNA of the Pancreas: Follow-Up and Outcomes Evan A. Alston, MD 1 ; Sejong Bae, PhD 2 ; and Isam A. Eltoum, MD, MBA 1 BACKGROUND:
More informationCK20 and p53 Immunohistochemical Staining Patterns in Urinary Bladder Specimens With Equivocal Atypia. Correlation With Outcomes
CK20 and p53 Immunohistochemical Staining Patterns in Urinary Bladder Specimens With Equivocal Atypia Correlation With Outcomes Javier A. Arias-Stella III, MD; Alpa B. Shah, MD, MPH; Nilesh S. Gupta, MD;
More informationCase 3 - GYN. History: 66 year old, routine Pap test. Dr. Stelow
Case 3 - GYN History: 66 year old, routine Pap test Dr. Stelow Case 3 66 year year old woman Routine Pap Test Cytologic Features 3 dimensional clusters of cells with small to moderate amount of
More informationPrepared By Jocelyn Palao and Layla Faqih
Prepared By Jocelyn Palao and Layla Faqih The structure of the suspected atypical cell should always be compared to the structure of other similar, benign, cells which are present in the smears. The diagnosis
More informationThe role of the cytologist in breast cancer screening
The role of the cytologist in breast cancer screening I.Seili-Bekafigo, MD, PhD Clinical cytologist KBC Rijeka Croatian Society for Clinical Cytology Fine needle aspiration (FNA, FNAB, FNAC) Fine needle
More informationGUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER
GUIDELINES ON NON-MUSCLE- INVASIVE BLADDER CANCER (Limited text update December 21) M. Babjuk, W. Oosterlinck, R. Sylvester, E. Kaasinen, A. Böhle, J. Palou, M. Rouprêt Eur Urol 211 Apr;59(4):584-94 Introduction
More informationUrothelial Carcinoma: Is Urine Cytology an Important Diagnostic Test?
Original Article Urothelial Carcinoma: Is Urine Cytology an Important Diagnostic Test? Ghazala Mudassar 1, Ashok Kumar Tanwani 2, HumaMushtaq 3, Saeed Alam 4 1 Assistant Professor Pathology, Shifa College
More informationAP110 URINARY BLADDER BIOPSY INTERPRETATION Part 1
AP110 URINARY BLADDER BIOPSY INTERPRETATION Part 1 Mahul B. Amin, MD Director of Surgical Pathology, Emory University Hospital Professor of Pathology, Urology, Hematology & Oncology, Emory University School
More informationThyroid master class. Thyroid Fine needle aspiration cytology and liquid-based techniques: Hologic and Becton Dickinson
Thyroid master class Thyroid Fine needle aspiration cytology and liquid-based techniques: Hologic and Becton Dickinson Principle of LBC Collection of cells in liquid medium Immediate fixation Processor-prepared
More informationHPV Testing & Cervical Cancer Screening:
HPV Testing & Cervical Cancer Screening: Are they linked? By William Chapman, MD, FRCPC Screening for precursor lesions of cervical cancer by the Papanicolaou (Pap) smear has been one of the greatest success
More informationCan Use the NMP22 BladderChek Decrease the Frequency of Cystoscopy in the Follow up of Patients with Bladder Carcinoma?
Original Article Int J Nephrol Urol, 2009; 1(1):51-55 Can Use the NMP22 BladderChek Decrease the Frequency of Cystoscopy in the Follow up of Patients with Bladder Carcinoma? Adel Allam 1*, Badawi Hathout
More informationNew Diagnoses Need New Approaches: A Glimpse into the Near Future of Gynecologic Pathology
New Diagnoses Need New Approaches: A Glimpse into the Near Future of Gynecologic Pathology United States and Canadian Academy of Pathology 102 nd Annual Meeting Baltimore, Maryland Christina S. Kong, M.D.
More informationRates of thyroid malignancy by FNA diagnostic category
Williams et al. Journal of Otolaryngology - Head and Neck Surgery 2013, 42:61 ORIGINAL RESEARCH ARTICLE Open Access Rates of thyroid malignancy by diagnostic category Blair A Williams 1*, Martin J Bullock
More information2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms: Inherent Problems and Clinical Reflections
european urology supplements 8 (2009) 453 457 available at www.sciencedirect.com journal homepage: www.europeanurology.com 2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms:
More informationMorphologic Features Which Affect Validation And Proficiency Test Performance Of BiopsyProven HSIL Pap Tests. The ASCP GYN PT & Assessment Committee
Morphologic Features Which Affect Validation And Proficiency Test Performance Of BiopsyProven HSIL Pap Tests The ASCP GYN PT & Assessment Committee The ASCP GYN PT & Assessment Committee Robert A. Goulart,
More informationLessons From Cases of Screened Women Who Developed Cervical Carcinoma
Lessons From Cases of Screened Women Who Developed Cervical Carcinoma R. Marshall Austin MD,PhD Magee-Womens Hospital of University of Pittsburgh Medical Center raustin@magee.edu Why Focus Study On Cases
More informationOutline 11/2/2017. Pancreatic EUS-FNA general aspects. Cytomorphologic features of solid neoplasms/lesions of the pancreas
ENDOSCOPIC ULTRASOUND GUIDED-FINE NEEDLE ASPIRATION CYTOLOGY OF PANCREAS Khalid Amin M.D. Assistant Professor Department of Laboratory Medicine and Pathology University of Minnesota Outline Pancreatic
More informationRole of fine needle aspiration cytology and cytohistopathological co-relation in thyroid lesions: experience at a tertiary care centre of North India
International Journal of Research in Medical Sciences Chandra S et al. Int J Res Med Sci. 2016 Oct;4(10):4552-4556 www.msjonline.org pissn 2320-6071 eissn 2320-6012 Research Article DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20163328
More informationOverview of Indeterminate Cytology
83 rd Annual Meeting American Thyroid Association Overview of Indeterminate Cytology Scott Boerner MD FRCPC Head Cytopathology, University Health Network University of Toronto DISCLOSURE Nothing to disclose
More informationCervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013
Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines General Principles: Since its introduction in 1943, Papanicolaou (Pap) smear is widely
More informationCytology for the Endocrinologist. Nicole Massoll M.D
Cytology for the Endocrinologist Nicole Massoll M.D Objectives Discuss slide preperation Definitions of adequacy ROSE (Rapid On-Site Evaluation) Thyroid Cytology Adequacy Nicole Massoll M.D. University
More informationCytomorphologic Thresholds for Classifying Thyroid FNAs as Suspicious and Positive for PTC
Cytomorphologic Thresholds for Classifying Thyroid FNAs as Suspicious and Positive for PTC Tarik M. Elsheikh, MD Professor and Medical Director Anatomic Pathology Cleveland Clinic Laboratories Case Study
More informationXIII CONGRESSO NAZIONALE Roma, 7-9 novembre NODULO TIROIDEO: Agoaspirato o Core Needle Biopsy?
XIII CONGRESSO NAZIONALE NODULO TIROIDEO: Agoaspirato o Core Needle Biopsy? Anna Crescenzi Policlinico Universitario Campus Bio-Medico Roma Indeterminate lesions are heterogeneous The gray zone CONSERVATIVE
More information3/22/2017. Disclosure of Relevant Financial Relationships. Cytomorphologic Thresholds for Classifying Thyroid FNAs as Suspicious and Positive for PTC
Cytomorphologic Thresholds for Classifying Thyroid FNAs as Suspicious and Positive for PTC Tarik M. Elsheikh, MD Professor and Medical Director Anatomic Pathology Cleveland Clinic Laboratories Disclosure
More informationINTRADUCTAL LESIONS OF THE PROSTATE. Jonathan I. Epstein
INTRADUCTAL LESIONS OF THE PROSTATE Jonathan I. Epstein Topics Prostatic intraepithelial neoplasia (PIN) Intraductal adenocarcinoma (IDC-P) Intraductal urothelial carcinoma Ductal adenocarcinoma High Prostatic
More information5/21/2018. Prostate Adenocarcinoma vs. Urothelial Carcinoma. Common Differential Diagnoses in Urological Pathology. Jonathan I.
Common Differential Diagnoses in Urological Pathology Jonathan I. Epstein Prostate Adenocarcinoma vs. Urothelial Carcinoma 1 2 NKX3.1 NKX3.1 3 4 5 6 Proposed ISUP Recommendations Option to use PSA as a
More informationAlthough current American Cancer Society guidelines
ORIGINAL ARTICLE Diffuse Adenosis of the Peripheral Zone in Prostate Needle Biopsy and Prostatectomy Specimens Tamara L. Lotan, MD* and Jonathan I. Epstein, MD*w z Abstract: We have observed a group of
More informationCytyc Corporation - Case Presentation Archive - July 2002
ThinPrep Pap Test History: 34 Year Old Female LMP: Day 20 Specimen Type: Cervical/Vaginal Case provided by Mark Tulecke, M.D. and Gabrielle Trawinski CT (ASCP), Mount Auburn Hospital, Cambridge, Massachusetts.
More informationsystem and the Bethesda system applied for reporting thyroid cytopathology
Original Research Article A comparative study between conventional system and the Bethesda system applied for reporting thyroid cytopathology M. Mamatha 1*, S. Chandra Sekhar 2, H. Sandhya Rani 3, S. Sandhya
More informationCase #1 FNA of nodule in left lobe of thyroid in 67 y.o. woman
Challenging Cases Manon Auger M.D., F.R.C.P. (C) Professor, Department of Pathology McGill University Director, Cytopathology Laboratory McGill University it Health Center Case #1 FNA of nodule in left
More informationVilloglandular adenocarcinoma of cervix a tumour with bland cytological features: report of a case missed on cytology
Malaysian J Pathol 2003; 25(2) : CERVICAL 139 143 VILLOGLANDULAR ADENOCARCINOMA CYTOLOGY CASE REPORT Villoglandular adenocarcinoma of cervix a tumour with bland cytological features: report of a case missed
More informationCase #1. Ed Stelow, MD University of Virginia
Case #1 Ed Stelow, MD University of Virginia Imagine, If You Will It s 4:30 on Friday Last cytology case A thyroid FNA from outside that did not have any onsite interpretation It is from a 45-year old
More informationThe Korean Journal of Cytopathology 15(1) : 60-64, 2004
15 1 The Korean Journal of Cytopathology 15(1) : 60-64, 2004 : INTRODUCTION Papillary carcinoma of the thyroid gland has for long been traditionally diagnosed on the basis of the characteristic papillary
More information